MYM Nutraceuticals, Inc. (OTC: MYMMF) Rob Gietl, CEO Interview. Medicinal cannabis company projects “$3 billion revenues in 2020”.

 

 

 

 

MYM Nutraceuticals, Inc. (CSE: MYM) (OTC: MYMMF) CEO Interview with Rob Gietl, discussing progress toward the company’s goal of becoming a vertically integrated player in the medicinal cannabis space, with a multi-national footprint. Rob addresses the recent CDN$50 million shelf offering, cannabis growing facilities coming online, starting in Q1 2019, and his objective of “$3 billion revenues in 2020”.

 

 

Investor Presentation

MYM Nutraceutical

 

 

Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.